Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Catalyst Pharm Inc (CPRX)

3.7   -0.01 (-0.27%) 01-27 02:46
Open: 3.76 Pre. Close: 3.71
High: 3.8 Low: 3.66
Volume: 1,351,481 Market Cap: 383M
Catalyst Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with lambert-eaton myasthenic syndrome. The company also develops Firdapse, which is in various clinical trials for the treatment of patients with congenital myasthenic syndrome, anti-MuSK antibody positive myasthenia gravis, and spinal muscular atrophy type 3. Catalyst Pharmaceuticals, Inc. has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was formerly known as Catalyst Pharmaceutical Partners, Inc. and changed its name to Catalyst Pharmaceuticals, Inc. in May 2015. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.805 - 3.823 3.823 - 3.842
Low: 3.606 - 3.629 3.629 - 3.652
Close: 3.657 - 3.694 3.694 - 3.73

Technical analysis

as of: 2021-01-26 4:42:31 PM
Overall:       
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 4.44     One year: 5.18
Support: Support1: 3.49    Support2: 3.30
Resistance: Resistance1: 3.80    Resistance2: 4.44
Pivot: 3.57
Moving Average: MA(5): 3.67     MA(20): 3.53
MA(100): 3.36     MA(250): 3.92
MACD: MACD(12,26): 0.05     Signal(9): 0.03
Stochastic oscillator: %K(14,3): 73.53     %D(3): 72.92
RSI: RSI(14): 59.11
52-week: High: 5.28  Low: 2.55  Change(%): -14.5
Average Vol(K): 3-Month: 173431  10-Days: 153874

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
CPRX has closed below upper band by 10.7%. Bollinger Bands are 23.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 21 Jan 2021
Could The Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Ownership Structure Tell Us Something Useful? - Simply Wall St

Wed, 20 Jan 2021
Where Does Wall Street Think Catalyst Pharmaceuticals Inc (CPRX) Stock Will Go? - InvestorsObserver

Sun, 17 Jan 2021
Validea's Top Five Healthcare Stocks Based On David Dreman - 1/17/2021 - Nasdaq

Tue, 12 Jan 2021
What is Wall Street's Target Price for Catalyst Pharmaceuticals Inc (CPRX) Stock? - InvestorsObserver

Fri, 08 Jan 2021
CPRX: 3 Biotech Stocks on the Robinhood 100 to AVOID - StockNews.com

Thu, 07 Jan 2021
Catayst (CPRX) Provides Long-Term Portfolio Expansion Plans - Nasdaq

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Outperform Price to Earnings: Outperform
Return on Equity: Outperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 104
Shares Float (M) 86
% Held by Insiders 6.98
% Held by Institutions 69.58
Shares Short (K) 12,280
Shares Short P. Month (K) 13,440

Stock Financials

EPS 0.670
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 1.510
Profit Margin 60.48
Operating Margin 34.43
Return on Assets (ttm) 18.7
Return on Equity (ttm) 60.9
Qtrly Rev. Growth -5.1
Gross Profit (p.s.) 0.845
Sales Per Share 1.140
EBITDA (p.s.) 0.394
Qtrly Earnings Growth 218.00
Operating Cash Flow (M) 44
Levered Free Cash Flow (M) 30

Stock Valuations

PE Ratio 5.52
PEG Ratio
Price to Book value 2.45
Price to Sales 3.24
Price to Cash Flow 8.67

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.